Skip to main content

Advertisement

SpringerLink
Log in

Metastatic melanoma: how research can modify the course of a disease

  • Published:
Cancer and Metastasis Reviews Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Levesque, M., Cheng, P., Raaijmakers, M., Saltari, A., & Dummer, R. (2017). Metastatic melanoma moves on: translational science in the era of personalized medicine. Cancer Metastasis Rev, 36(1), 7–21. doi:10.1007/s10555-017-9658-0.

  2. Meierjohann, S. (2017). Crosstalk signaling in targeted melanoma therapy. Cancer Metastasis Rev, 36(1), 23–33. doi:10.1007/s10555-017-9659-z.

  3. Queirolo, P., & Spagnolo, F. (2017). BRAF plus MEK-targeted drugs: a new standard of treatment for BRAF-mutant advanced melanoma. Cancer Metastasis Rev, 36(1), 35–42. doi:10.1007/s10555-017-9660-6.

  4. Hermel, D., & Ott, P. (2017). Combining forces: the promise and peril of synergistic immune checkpoint blockade and targeted therapy in metastatic melanoma. Cancer Metastasis Rev, 36(1), 43–50. doi:10.1007/s10555-017-9656-2.

  5. Kunz, M., & Hölzel, M. (2017). The impact of melanoma genetics on treatment response and resistance in clinical and experimental studies. Cancer Metastasis Rev, 36(1), 53–75. doi:10.1007/s10555-017-9657-1.

  6. Leachman, S. A., Lucero, O., Sampson, J. E., Cassidy, P., Bruno, W., Queirolo, P., et al. (2017). Identification, genetic testing, and management of hereditary melanoma. Cancer Metastasis Rev, 36(1), 77–90. doi:10.1007/s10555-017-9661-5.

  7. Filipp, F. V. (2017). Precision medicine driven by cancer systems biology. Cancer Metastasis Rev, 36(1), 91–108. doi:10.1007/s10555-017-9662-4.

  8. Amaro, A., Gangemi, R., Angelini, G., Barisione, G., Ferrini, S., & Pfeffer, U. (2017). The biology of uveal melanoma. Cancer Metastasis Rev, 36(1), 109–140. doi:10.1007/s10555-017-9663-3.

Download references

Author information

Authors and Affiliations

  1. Department of Integrated Oncological Therapies, IRCCS AOU San Martino – IST Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy

    Paola Queirolo & Ulrich Pfeffer

Authors
  1. Paola Queirolo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ulrich Pfeffer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ulrich Pfeffer.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Queirolo, P., Pfeffer, U. Metastatic melanoma: how research can modify the course of a disease. Cancer Metastasis Rev 36, 3–5 (2017). https://doi.org/10.1007/s10555-017-9664-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10555-017-9664-2

Keywords

Search

Navigation